PepperLedger
COMPOUND LIBRARY·NAC
COMPOUND PROFILE · PEPPERLEDGER

NAC (N-Acetylcysteine)

Type
Semi-synthetic amino acid derivative — N-acetyl-L-cysteine, the acetylated form of L-cysteine with improved stability and oral bioavailability
Class
Glutathione precursor · Mucolytic · Antioxidant · Cysteine donor · Neuroprotectant
Administration
Oral capsule (primary) · IV (approved for acetaminophen overdose and respiratory indications) · Nebulized (respiratory) · Sublingual
Half-life
~6 hours — twice daily dosing for sustained glutathione support
Most studied use
Glutathione repletion · Liver protection · Respiratory health (COPD, cystic fibrosis) · OCD and psychiatric conditions · Addiction treatment · Fertility · Longevity
Regulatory status
FDA-approved drug (IV and oral) for acetaminophen overdose and respiratory conditions · Available OTC as a dietary supplement
Human evidence
Exceptional — decades of approved medical use plus RCTs in respiratory disease, liver disease, psychiatric conditions, addiction, and fertility
Preclinical evidence
Extensive — glutathione synthesis pathway and glutamate modulation mechanisms are well-characterized

EDUCATIONAL TOOL — NOT MEDICAL ADVICE

What is NAC?

NAC is the glutathione precursor that actually works orally. The challenge with oral glutathione supplementation is that the GI tract degrades the tripeptide before meaningful absorption occurs — most swallowed glutathione arrives in the bloodstream as its component amino acids. NAC bypasses this by providing cysteine, the rate-limiting amino acid in glutathione synthesis, in a stable, well-absorbed form. Inside cells, NAC is deacetylated to L-cysteine, which is combined with glutamate and glycine by gamma-glutamylcysteine synthetase to synthesize fresh intracellular glutathione where it’s needed. This makes NAC more effective at raising intracellular GSH than direct glutathione supplementation in most contexts.

NAC has an unusually broad and well-evidenced clinical profile. It’s FDA-approved as the primary treatment for acetaminophen (Tylenol) overdose, where it works by restoring hepatic glutathione depleted by toxic acetaminophen metabolites — preventing liver failure. This established its hepatoprotective mechanism at the highest level of regulatory certainty. Beyond this primary approval, NAC has extensive evidence in respiratory disease (a mucolytic for COPD, cystic fibrosis, and bronchitis that breaks down mucus disulfide bonds), OCD and other psychiatric conditions, addiction, male fertility, polycystic ovary syndrome, and kidney protection from contrast agents.

For the biohacker and longevity audience, NAC’s primary application is glutathione maintenance — supporting the master antioxidant that declines with age, is depleted by oxidative stress from compound stacks and training, and is required for liver detoxification of everything the body processes. For users running multiple peptide protocols, GLP-1 compounds, and other agents, NAC is a sensible foundational protective layer that keeps the cellular redox environment from being overwhelmed — often discussed alongside TUDCA as part of a liver-support stack.

An important recent note: the FDA attempted to remove NAC from the supplement market in 2021, arguing it had been excluded from supplement status because it had previously been studied as a drug. This created significant concern in the supplement industry and biohacker community. The FDA reversed course in 2022, clarifying that NAC can remain a lawfully marketed supplement. This controversy had no bearing on NAC’s safety or efficacy — it was entirely a regulatory classification issue.

How it works

Glutathione Precursor — The Rate-Limiting Step

Glutathione synthesis proceeds in two steps: L-glutamate + L-cysteine combine to form gamma-glutamylcysteine, the rate-limiting reaction catalyzed by glutamate-cysteine ligase (GCL) using cysteine as substrate, and this is then combined with glycine to form glutathione (GSH). Cysteine availability is the rate-limiting factor — dietary cysteine is limited, and free cysteine is unstable and poorly absorbed. NAC provides cysteine in a stable, well-absorbed form that crosses cell membranes, is deacetylated intracellularly, and feeds the GCL reaction directly. Studies consistently show NAC supplementation raises intracellular GSH more effectively than oral glutathione at equivalent doses.

Mucolytic Activity

NAC breaks disulfide bonds in mucus glycoproteins — the cross-links that make mucus viscous and difficult to clear in respiratory disease. Free thiol groups from NAC, after deacetylation, cleave disulfide bonds, reducing mucus viscosity and improving airway clearance. This mechanism is entirely distinct from glutathione synthesis and explains NAC’s established efficacy in COPD, cystic fibrosis, and chronic bronchitis.

Glutamate Modulation — Psychiatric Mechanism

NAC modulates glutamate neurotransmission through the cystine-glutamate antiporter (system Xc-). By providing cysteine, NAC drives this transporter to release glutamate into the synapse in exchange for cystine uptake. This glutamate release activates inhibitory mGluR2/3 autoreceptors, reducing the pathologically elevated glutamate signaling implicated in OCD, addiction, and other psychiatric conditions. This mechanism behind NAC’s psychiatric and addiction evidence is entirely independent of glutathione synthesis.

What the research shows

STUDYJournal of Clinical Pharmacy and Therapeutics · 2016

N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial

Paydary K, Akamaloo A, Ahmadipour A, et al.

A randomized, double-blind, placebo-controlled trial found that NAC augmentation of standard OCD treatment significantly reduced Y-BOCS symptom scores with acceptable tolerability — one of the cleanest RCT demonstrations of NAC's glutamate-modulation mechanism in a psychiatric condition.

View on PubMed →
STUDYBMC Medicine · 2007

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity

Gonzales DA, Norsworthy KJ, Kern SJ, et al.

A meta-analysis of randomized trials found that oral NAC given around contrast exposure significantly reduces contrast-induced acute kidney injury — one of the most-replicated clinical findings for NAC and a widely used preventive protocol in cardiology and radiology.

View on PubMed →
WHAT THE RESEARCH SHOWS
KNOWN
  • NAC raises intracellular glutathione more effectively than oral glutathione, which has negligible systemic availability
  • FDA-approved antidote for acetaminophen overdose via hepatic glutathione restoration
  • Significant OCD symptom reduction demonstrated in an RCT via glutamate modulation
  • Reduces contrast-induced nephropathy risk in meta-analyzed trials
  • Established mucolytic for COPD, cystic fibrosis, and chronic bronchitis
?UNCERTAIN
  • ?Optimal dose for longevity/maintenance use versus acute medical applications
  • ?Long-term effects of daily NAC on glutathione homeostasis
  • ?Whether chronic NAC blunts beneficial ROS signaling from exercise

What the community reports

NAC is one of the most widely used and least controversial supplements in the biohacker community — cheap, well-tolerated, and backed by decades of medical use.

Liver support staple — used alongside any hepatotoxic compounds, including SARMs, oral steroids, and alcohol, and the most consistent community application
Post-illness recovery — users report faster recovery from illness when NAC is in the protocol, consistent with glutathione’s role in immune function
The hangover application — NAC before and after alcohol significantly reduces hangover severity for many users, consistent with NAC replenishing the glutathione depleted by alcohol metabolism
Respiratory benefits — users with chronic respiratory issues or frequent illness report improved breathing and reduced mucus with regular NAC
Effervescent form preference — many users prefer NAC effervescent tablets over capsules for better absorption and palatability, and this form is standard in European markets
The exercise ROS debate — some evidence suggests NAC may blunt beneficial ROS signaling during exercise that drives adaptations, similar to the vitamin C/E antioxidant debate, and the community is divided on taking it pre-workout versus post-workout only

Common misconceptions

“NAC and glutathione are interchangeable.”

REALITY

NAC is a glutathione precursor that raises intracellular GSH through synthesis. Oral glutathione is largely degraded in the GI tract before absorption. For raising intracellular glutathione — where antioxidant and detoxification effects actually occur — NAC is more effective. IV glutathione bypasses this limitation, but for oral use, NAC is the better-supported choice.

“More NAC means more glutathione indefinitely.”

REALITY

Glutathione synthesis has multiple regulatory points beyond cysteine availability — GCL activity is feedback-regulated by GSH itself. Once intracellular GSH is replete, additional NAC produces diminishing returns and excess cysteine is diverted to other pathways. Standard doses of 600-1200 mg/day are sufficient for maintenance; higher doses don’t proportionally increase GSH.

“NAC blunts all exercise adaptations.”

REALITY

Some evidence suggests high-dose antioxidants can blunt ROS-mediated exercise adaptations. The evidence for NAC specifically at typical supplemental doses is mixed — some studies show effects, others don’t. Taking NAC post-workout rather than pre-workout may minimize any interference while still providing recovery support, but this remains an open question, not a settled concern.

AI COACH PREVIEW
I run multiple peptide protocols and want to protect my liver and maintain glutathione levels. How should I dose NAC?
For general protective use alongside other protocols, NAC is typically dosed in the 600-1200 mg/day range, split into two doses with meals to reduce GI side effects - that's the range supported by the maintenance literature, and going much higher doesn't proportionally raise glutathione once you're replete. Where it gets more specific is if any of your current compounds are notably hepatotoxic - in that case, NAC is often paired with TUDCA as a more comprehensive liver-support pairing, since they work through different mechanisms (glutathione precursor versus bile acid modulation). What does your current stack look like? That would help me think about whether the standard maintenance dose covers it or whether a more protective protocol around specific compounds makes sense, and what to track in your liver panel to confirm it's working.
CONTINUE IN THE APP

Open PepperLedger to track your NAC protocol →

Free to join. No credit card. Ask the Coach about NAC dosing, liver protection stacks, and glutathione support.

Free to join · No credit card · 23-day Pro trial included

PepperLedger

Educational tool — not medical advice. PepperLedger is a logging and information tool for adults managing their own protocols. It does not prescribe, diagnose, or treat anything. Always work with a qualified healthcare provider for medical decisions.

© 2026 Realee AI · PepperLedger